Navigation Search

SALIENTVALUE


7 Key Healthcare Value Drivers in 2018

By David Coit, DBA, CVA, CVGA, CMAA Volume 5 Issue 3, January 30, 2018  Today’s turbulent healthcare industry offers many challenges for healthcare executives. Despite this, providers can create significant value that will help them to build their healthcare businesses, finance growth, and ultimately sell their companies for the best price. Seven key value drivers for…

READ MORE

7 Ways Buyers Can Easily Blow Healthcare Transactions

By Tom Schramski, Managing Partner Volume 5 Issue 2, January 16, 2018  Much of the literature on failed healthcare transactions focuses on seller-related problems – unrealistic expectations, poor margins, a troubled market, and even fraudulent financial reporting. But it takes two to tango and buyers have their role. Sometimes, they lack other-awareness in the following ways: Not…

READ MORE

5 Tragic Outcomes Of Competitive Bidding (Or How The Cure Became Worse Than The Problem)

By Eric Hymes, Managing Director Volume 5 Issue 1, January 2, 2018  The Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) was mandated by Congress through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). This legislation was largely a response to multiple cases of profiteering by unsavory DME companies in…

READ MORE

6 Reasons Why 2018 Will Be The Year Of Healthcare Consolidation

By the Managing Directors of VERTESS Volume 4 Issue 26, December 19, 2017  We have entered an era of unprecedented consolidation of healthcare organizations. Whether nonprofit or for profit, large of small, DME or I/DD, consolidation is inescapable and on the mind of every healthcare business owner or executive in America. The continuing unknowns of Trumpcare,…

READ MORE

6 Directions For The New Addictions Rx Marketplace

By Tom Schramski, PhD, CMAA Volume 4 Issue 25, December 5, 2017  Nearly 50 years ago, Anais Nin wrote that “we don’t see things as they are, we see things as we are.” Her observation about human projection fits well for the addictions treatment market where we are in the midst of continuing evolution. One of the…

READ MORE

5 Reasons ASCs Are Dominating The Healthcare Marketplace

By Hilsman Knight, Managing Director Volume 4 Issue 24, November 21, 2017  Ambulatory Surgery Centers (ASCs) have rapidly become an preferred option for outpatient procedure services. As a result, the procedures that had been traditionally preformed in hospital settings have been transitioning more to the ASC model and previously designated inpatient procedures are now classified as outpatient…

READ MORE

7 Faces Of The Coming I/DD Revolution

By Tom Schramski, PhD, CMAA, Joshua Boynton, CMAA, Drew Smith, MBA, and Kelly Friedlander, MSW, MPA Volume 4 Issue 23, November 7, 2017  During the past 50 years, we have experienced profound change in the services and support for people with intellectual/developmental disabilities. Many large, costly, and dehumanizing institutions have closed, while community supports promoting inclusion and self-direction have blossomed…

READ MORE

7 Critical Market Trends DME/HME Executives Need To Consider Today

By Bradley Smith, ATP, CMAA Volume 4 Issue 22, October 24, 2017  The rapidly evolving DME/HME market continues to grow in volume despite significant downward pressure from insurers. This market has experienced significant consolidation in recent years, in part as a result of fee schedule changes introduced by the Centers for Medicare & Medicaid Services (CMS). Further…

READ MORE

9 Great Reasons To Hire A Healthcare M+A Advisor

By Teresa Gonzalo, PharmD, PHD, MBA, CMAA Volume 4 Issue 21, October 10, 2017  From time to time I am asked the following question: Why should I hire a specialized merger and acquisition advisor or investment banker for my healthcare company? A simple answer would be, because it´s a win-win situation for all the parties involved. A…

READ MORE

The 5 Silver Linings Of Value-Based I/DD Services

By Joshua Boynton Volume 4 Issue 20, September 26, 2017  Created in 1965, the Federal Medicaid program today covers 74 million people in the US, with expenditures of over $500 billion each year. Within this population are five million people with an intellectual/developmental disability (I/DD), 700,000 of which are receiving financial support through the Home and Community-Based…

READ MORE